Brief: Vera Therapeutics Q3 EPS USD -1.26 Vs. IBES Estimate USD -1.17
05/11/2025 12:29
Nov 05 (Reuters) - Vera Therapeutics Q3 operating income USD -83.932 million vs. IBES estimate USD -77.3 million. Q3 operating expenses USD 83.932 million Q3 net income USD -80.293 million vs. IBES estimate USD -75.8 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial